Gastroesophageal Reflux Disease in Adults
Course #94902 - $60 -
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
Gastroesophageal reflux disease (GERD) is recognized as a complex clinical entity, primarily a motility disorder with impaired lower esophageal sphincter structure and function playing a central role. However, GERD is widely seen as a simple disorder of acid over-secretion resolved by proton pump inhibitor (PPI) medication. While PPIs are the backbone of clinical management for patients with suspected GERD, many patients remain symptomatic even after initiating treatment. This reflects the diverse underlying pathology of GERD symptom presentation that requires proper diagnosis to effectively target with therapy. There is an increase in publications associating long-term PPI therapy with concerning adverse effects. This course will disentangle the conflicting and sometimes confusing clinical guidance and evidence that characterizes the large volume of publications on GERD, empowering primary care clinicians with the clarity and direction to improve the clinical care of these patients.
- INTRODUCTION
- DEFINITIONS AND DESCRIPTIONS
- EPIDEMIOLOGY OF GERD
- ESOPHAGEAL COMPLICATIONS
- PREDISPOSING AND RISK FACTORS FOR GERD
- NATURAL HISTORY OF GERD
- PATHOGENESIS AND PATHOPHYSIOLOGY
- SYMPTOMS ASSOCIATED WITH GERD
- DIAGNOSIS OF GERD
- INITIAL MANAGEMENT OF GERD
- MANAGEMENT OF GERD IN PATIENTS NONRESPONSIVE TO PPIs
- ANTIREFLUX SURGERY
- CONSIDERATIONS FOR NON-ENGLISH-PROFICIENT PATIENTS
- CONCLUSION
- Works Cited
- Evidence-Based Practice Recommendations Citations
This course is designed for physicians, nurses, and members of the interprofessional healthcare team involved in the diagnosis, treatment, and care of patients with gastroesophageal reflux disease (GERD).
The purpose of this course is to provide members of the interprofessional healthcare team with the information necessary to appropriately diagnose, treat, and care for patients with GERD.
Upon completion of this course, you should be able to:
- Outline the incidence and prevalence of gastroesophageal reflux disease (GERD).
- Describe the patient, social, and economic impact of GERD.
- Identify risk factors for GERD.
- Review the natural history and pathophysiology of GERD.
- Appropriately categorize GERD according to underlying pathology.
- Identify signs and symptoms of GERD.
- Select appropriate diagnostic tests for patients with suspected GERD.
- Analyze the pharmacologic treatment of GERD.
- Outline the treatment options for refractory GERD.
- Describe surgical options for GERD treatment.
Mark Rose, BS, MA, LP, is a licensed psychologist in the State of Minnesota with a private consulting practice and a medical research analyst with a biomedical communications firm. Earlier healthcare technology assessment work led to medical device and pharmaceutical sector experience in new product development involving cancer ablative devices and pain therapeutics. Along with substantial experience in addiction research, Mr. Rose has contributed to the authorship of numerous papers on CNS, oncology, and other medical disorders. He is the lead author of papers published in peer-reviewed addiction, psychiatry, and pain medicine journals and has written books on prescription opioids and alcoholism published by the Hazelden Foundation. He also serves as an Expert Advisor and Expert Witness to law firms that represent disability claimants or criminal defendants on cases related to chronic pain, psychiatric/substance use disorders, and acute pharmacologic/toxicologic effects. Mr. Rose is on the Board of Directors of the Minneapolis-based International Institute of Anti-Aging Medicine and is a member of several professional organizations.
Contributing faculty, Mark Rose, BS, MA, LP, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
John M. Leonard, MD
Mary Franks, MSN, APRN, FNP-C
The division planners have disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Sarah Campbell
The Director of Development and Academic Affairs has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
The purpose of NetCE is to provide challenging curricula to assist healthcare professionals to raise their levels of expertise while fulfilling their continuing education requirements, thereby improving the quality of healthcare.
Our contributing faculty members have taken care to ensure that the information and recommendations are accurate and compatible with the standards generally accepted at the time of publication. The publisher disclaims any liability, loss or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents. Participants are cautioned about the potential risk of using limited knowledge when integrating new techniques into practice.
It is the policy of NetCE not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Supported browsers for Windows include Microsoft Internet Explorer 9.0 and up, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Supported browsers for Macintosh include Safari, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Other operating systems and browsers that include complete implementations of ECMAScript edition 3 and CSS 2.0 may work, but are not supported. Supported browsers must utilize the TLS encryption protocol v1.1 or v1.2 in order to connect to pages that require a secured HTTPS connection. TLS v1.0 is not supported.
The role of implicit biases on healthcare outcomes has become a concern, as there is some evidence that implicit biases contribute to health disparities, professionals' attitudes toward and interactions with patients, quality of care, diagnoses, and treatment decisions. This may produce differences in help-seeking, diagnoses, and ultimately treatments and interventions. Implicit biases may also unwittingly produce professional behaviors, attitudes, and interactions that reduce patients' trust and comfort with their provider, leading to earlier termination of visits and/or reduced adherence and follow-up. Disadvantaged groups are marginalized in the healthcare system and vulnerable on multiple levels; health professionals' implicit biases can further exacerbate these existing disadvantages.
Interventions or strategies designed to reduce implicit bias may be categorized as change-based or control-based. Change-based interventions focus on reducing or changing cognitive associations underlying implicit biases. These interventions might include challenging stereotypes. Conversely, control-based interventions involve reducing the effects of the implicit bias on the individual's behaviors. These strategies include increasing awareness of biased thoughts and responses. The two types of interventions are not mutually exclusive and may be used synergistically.